Fatigue News and Research

RSS

Study links slowed processing speed with executive deficits in individuals with multiple sclerosis

Kessler Foundation researchers have published a study supporting the role of slowed processing speed in the executive deficits found in individuals with multiple sclerosis (MS).

17 Sep 2014

Warwick researchers discover novel drug target for treating postpartum haemorrhage

Researchers at the University of Warwick have discovered a new target for drugs that could prevent the deaths of thousands of women in the developing world due to heavy blood loss after childbirth.

17 Sep 2014

Thoracic radiotherapy reduces cancer recurrence in SCLC patients, shows new study

Treating advanced small-cell lung cancer (SCLC) with thoracic (or chest) radiation therapy in addition to standard treatment significantly prolongs long-term survival and reduces cancer recurrence in the chest by almost 50%, according to new research published in The Lancet and being presented simultaneously at ASTRO's 2014 Annual Meeting in San Francisco.

16 Sep 2014

Viewpoints: Crediting the health law for modest premium increases; Hollywood misses the mark on sick teens

The rate of growth on premiums for employer-based health coverage in the first five months of this year was one of the lowest in 16 years. Despite longstanding concerns that employer-sponsored coverage might become too costly to sustain, that market seems to have stabilized for now .... Thanks to the Affordable Care Act, federal tax credit subsidies -; available for people earning up to 400 percent of the federal poverty level ($95,400 for a family of four) -; are helping to make these policies affordable and cushioning the impact of premium increases in some cities (9/14).

16 Sep 2014

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.

15 Sep 2014

Simple point-of-care testing device provides more rapid diagnosis of anemia

A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the disease.

15 Sep 2014

Vuzix, Rochester collaborate to prescribe fashion frames, lenses for M100 Smart Glasses wearers

Vuzix® Corporation, a leading supplier of Video Eyewear and Smart Glasses products in the consumer, commercial and entertainment markets, announced today a strategic collaboration with Rochester Optical to provide fashion frames and prescription lenses for M100 Smart Glasses wearers.

11 Sep 2014

Working memory may be underlying mechanism of cognitive reserve in MS

Kessler Foundation scientists have shown that working memory may be an underlying mechanism of cognitive reserve in multiple sclerosis (MS).

10 Sep 2014

Improper removal of personal protective gear increases risk for Ebola health care workers

A team of American infectious disease and critical care experts is alerting colleagues caring for Ebola patients that how they remove their personal protective gear can be just as crucial as wearing it to prevent exposure to the deadly virus.

10 Sep 2014

Lucideon announces collaboration with Knight Mechanical Testing

Lucideon, an international provider of materials development, testing and assurance, and Knight Mechanical Testing, an independent mechanical testing laboratory, are pleased to announce that they have entered into a Marketing and Commercial Collaboration Agreement. The agreement means that both partners will now be to offer a complete portfolio of testing and analysis services to the orthopaedic industry.

From Lucideon 10 Sep 2014

Researchers find that shared pain can boost actual group cooperation

What doesn't kill us may make us stronger as a group, according to findings from new research published in Psychological Science, a journal of the Association for Psychological Science.

10 Sep 2014

Researchers examine whether new drug offers added benefit for patients with chronic HCV

The drug simeprevir has been available since May 2014 for the treatment of adult patients with chronic hepatitis C infection.

9 Sep 2014

Ortho-oncology team successfully adapts shoulder surgical aid

An ortho-oncology team at Dartmouth-Hitchcock Norris Cotton Cancer Center successfully adapted a shoulder surgical aid (the Spider Limb Positioner) to conduct a left hip disarticulation on a melanoma patient as described in a case report published online in Medical Devices.

9 Sep 2014

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart failure and to reduce hospitalization for heart failure).

9 Sep 2014

Leading experts propose new treatment guidelines for chronic Lyme disease

Current treatments for Lyme disease, particularly chronic forms of the disease, are inadequate, according to a new treatment guideline written by a group of leading experts.

4 Sep 2014

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Bristol-Myers Squibb today announced the launch of Daklinza▼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.

4 Sep 2014

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

A little white pill may help scientists learn why patients with cystic fibrosis have less exercise capacity than their peers, even if their lungs are relatively healthy.

3 Sep 2014

Yoga program for MS patients improves physical and mental well-being

Paula Meltzer was only 38 when out of nowhere everything she looked at was blurry. For the single mother, who had a lucrative career as a gemologist and spent hours examining valuable pieces of jewelry, it seemed as if - in a split second - her life changed.

3 Sep 2014

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).

2 Sep 2014

Intravenous iron supplement can improve quality of life for iron deficient heart failure patients

Heart failure patients with iron deficiency can experience significant and sustainable improvements in functional capacity and quality of life as well as reduced risk of hospital admission for worsening heart failure by receiving just one to two intravenous doses of an iron supplement, according to the results of a study presented today at ESC Congress 2014.

30 Aug 2014

Fatigue News and Research

Study links slowed processing speed with executive deficits in individuals with multiple sclerosis

Warwick researchers discover novel drug target for treating postpartum haemorrhage

Thoracic radiotherapy reduces cancer recurrence in SCLC patients, shows new study

Viewpoints: Crediting the health law for modest premium increases; Hollywood misses the mark on sick teens

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Simple point-of-care testing device provides more rapid diagnosis of anemia

Vuzix, Rochester collaborate to prescribe fashion frames, lenses for M100 Smart Glasses wearers

Working memory may be underlying mechanism of cognitive reserve in MS

Improper removal of personal protective gear increases risk for Ebola health care workers

Lucideon announces collaboration with Knight Mechanical Testing

Researchers find that shared pain can boost actual group cooperation

Researchers examine whether new drug offers added benefit for patients with chronic HCV

Ortho-oncology team successfully adapts shoulder surgical aid

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Leading experts propose new treatment guidelines for chronic Lyme disease

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

Yoga program for MS patients improves physical and mental well-being

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

Intravenous iron supplement can improve quality of life for iron deficient heart failure patients

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News